David L. Dworzack - Concepedia

Author

David L. Dworzack

Creighton University

Also Known As

D L Dworzack, D. DWORZACK, D. L. DWORZACK, D. L. Dworzack, David Dworzack, David L. Dworzack

Publications

663

Citations

H-Index

Concepts

All Affiliations

Creighton University University of Kansas Medical Center United States Department of Veterans Affairs The University of Kansas Health System CHI Health Creighton University Medical Center - Bergan Mercy

About

David L. Dworzack is an author at Creighton University specializing in medicine, infection control, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	590
2	Health Sciences	5	5	255
3	Epidemiology	2	2	42
4	Biomedical Engineering	1	1	23
5	Emergency Medicine	1	1	14

David L. Dworzack

Publications

615

Citations

H-Index

Page 1

	Year	Citations
Pseudallescheria boydii Brain Abscess David L. Dworzack, Richard B. Clark, Winslow J. Borkowski, Medicine Miconazole DosageKlebsiella PneumoniaeLymphatic FilariasisPathologyClinical Infection	1989	75
Neurotoxicity of intrathecal gentamicin: A case report and experimental study Itaru Watanabe, Glenn R. Hodges, David L. Dworzack, Annals of Neurology NeurotoxicologyPeripheral NervesNeuroinflammationNeurobiology Of DiseaseCerebrospinal Fluid	1978	75
Zygomycosis of the Maxillary Sinus and Palate Caused by David L. Dworzack Archives of Internal Medicine Parasitic DiseaseMedicineOral CavityPathogenesisAmphotericin B	1978	63
Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins David L. Dworzack, M. P. Pugsley, Christine C. Sanders, European Journal of Clinical Microbiology & Infectious Diseases Gram-negative BacteriologyAntimicrobial SusceptibilityHealth SciencesAntibioticsAntimicrobial Resistance Gene	1987	60
Evaluation of single-dose ciprofloxacin in the eradication of Neisseria meningitidis from nasopharyngeal carriers David L. Dworzack, C. C. Sanders, Edward A. Horowitz, Antimicrobial Agents and Chemotherapy VaccinationAntimicrobial SusceptibilityNasopharyngeal CarriersAntibioticsPlacebo Recipients	1988	53
<i>Community-acquired Bacteremic</i>Achromobacter xylosoxidans<i>Type IIIa Pneumonia in a Patient with Idiopathic IgM Deficiency</i> David L. Dworzack, Consuelo M. Murray, Glenn R. Hodges, American Journal of Clinical Pathology Antimicrobial ChemotherapyKanamycin TherapyIiia PneumoniaAntimicrobial StewardshipHealthcare-associated Infection	1978	40
Efficacy of Ciprofloxacin in the Treatment of Nasopharyngeal Carriers of Neisseria meningitidis M. P. Pugsley, David L. Dworzack, Edward A. Horowitz, The Journal of Infectious Diseases Klebsiella PneumoniaeAntimicrobial ChemotherapyBacterial PathogensW. Eugene SandersDrug Resistance	1987	38
Pharmacological Evaluation of Cefaclor in Volunteers Glenn R. Hodges, Chien Liu, Daniel R. Hinthorn, Antimicrobial Agents and Chemotherapy Molecular PharmacologyUrologyPharmacological StudyMultiple DosesChronic Dosing	1978	34
Group B Streptococcal Infections in Adult Males David L. Dworzack, G R Hodges, William G. Barnes, The American Journal of the Medical Sciences AntibioticsAdult MalesHealthcare-associated InfectionVaginitisInfection Control	1979	30
Ceftriaxone therapy of serious bacterial infections in adults Marvin J. Bittner, David L. Dworzack, Laurel C. Preheim, Antimicrobial Agents and Chemotherapy Ceftriaxone TherapyAntimicrobial SusceptibilityHealth SciencesAntibioticsAntimicrobial Stewardship	1983	29

Page 1